National Institute of Dental & Craniofacial Research; Notice of Meeting, 1040-1041 [2018-00155]
Download as PDF
<![CDATA[
1040
Federal Register / Vol. 83, No. 6 / Tuesday, January 9, 2018 / Notices
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Lisa Wright-Solomon, the HRSA
Information Collection Clearance Officer
at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Radiation Exposure Screening and
Education Program, OMB No. 0906–
0012—Revision.
Abstract: The Radiation Exposure
Screening and Education Program
(RESEP) is authorized by section 417C
of the Public Health Service Act (42
U.S.C. 285a–9). The purpose of RESEP
is to assist individuals who live (or
lived) in areas where U.S. nuclear
weapons testing occurred and who are
diagnosed with cancer and other
radiogenic diseases caused by exposure
to nuclear fallout or nuclear materials
such as uranium. RESEP funds support
eligible health care organizations in
implementing cancer screening
programs; developing education
programs; disseminating information on
radiogenic diseases and the importance
of early detection; screening eligible
individuals for cancer and other
radiogenic diseases; providing
appropriate referrals for medical
treatment; and facilitating
documentation of radiation exposure.
Need and Proposed Use of the
Information: For this program,
performance measures were drafted to
provide data useful to the program and
to enable HRSA to provide aggregate
program data required by Congress
under the Government Performance and
Results Act of 1993 (Pub. L. 103–62).
These measures cover the principal
topic areas of interest to the Federal
Office of Rural Health Policy (FORHP),
including demographics for the RESEP
program user population, medical
screening activities for cancers and
other radiogenic diseases, exposure and
presentation types for eligible
radiogenic malignant and nonmalignant
diseases, referrals for appropriate
medical treatment, eligibility counseling
and referral assistance for the Radiation
Exposure Compensation Act, and
program outreach and education
activities. These measures speak to
FORHP’s progress toward meeting the
established goals. In order to reduce the
reporting burden by the award
recipients, a number of questions have
been removed with the new set of
measures reflecting an effort to
streamline data collection and collect
consistent and uniform measures across
FORHP’s grant programs.
Likely Respondents: Radiation
Exposure Screening and Education
Program award recipients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to: (1) Review instructions; (2)
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; (3) train
personnel and to be able to respond to
a collection of information; (4) search
data sources; to complete and review
the collection of information; and (5)
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Form name
Radiation Exposure Screening and Education Program .....
Average
burden per
response
(in hours)
Total
responses
Total
burden
hours
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2018–00145 Filed 1–8–18; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
15:58 Jan 08, 2018
Jkt 244001
1
8
12
96
8
HRSA specifically requests comments
on: (1) The necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
8
........................
8
........................
96
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Dental
and Craniofacial Research Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: January 31, 2018.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: Report to the Director, NIDCR.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room 6,
31 Center Drive, Bethesda, MD 20892.
Closed: 1:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room 6,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Alicia J. Dombroski, Ph.D.,
Director, Division of Extramural Activities,
E:\FR\FM\09JAN1.SGM
09JAN1
Federal Register / Vol. 83, No. 6 / Tuesday, January 9, 2018 / Notices
National Institute of Dental and Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892, 301–594–4805,
adombroski@nidcr.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 2, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–00155 Filed 1–8–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; MSM Program
Review (2018/05).
Date: February 12, 2018.
Time: 5:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy Plaza,
Suite 920, Bethesda, MD 20892 (Virtual
Meeting).
15:58 Jan 08, 2018
Dated: January 2, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–00154 Filed 1–8–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Confidentiality of Substance Use
Disorder Patient Records
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of public meeting.
AGENCY:
The Substance Abuse and
Mental Health Services Administration
(SAMHSA) announces that it will hold
a public listening session on
Wednesday, January 31, 2018, to solicit
information concerning the
Confidentiality of Substance Use
Disorder Patient Records regulations as
required by Section 11002 of the 21st
Century Cures Act. The listening session
will provide an opportunity for the
public to provide input to SAMHSA
concerning the effect of part 2 on
‘‘patient care, health outcomes, and
patient privacy’’ as well as potential
regulatory changes and future
subregulatory guidance.
DATES: The listening session will be
held on Wednesday, January 31, 2018,
from 8:30 a.m. (Eastern) to 1:00 p.m.
(Eastern).
FOR FURTHER INFORMATION CONTACT: For
information concerning the listening
session, please contact Rachel Karton,
Senior Legislative and Regulatory
Analyst, SAMHSA, 5600 Fishers Lane,
Rockville, MD 20857, (240) 276–0416 or
email PrivacyRegulations@
SAMHSA.hhs.gov.
SUPPLEMENTARY INFORMATION:
Participation: The Listening Session
proceeding will be recorded, and
subsequently archived and posted on
the SAMHSA website. The public may
attend the listening session:
• Via Teleconference/Webcast: The
entire proceeding will be streamed live
over the internet (requires prior
registration). Audio and streaming
information will be sent to those who
register prior to the meeting. Capacity
SUMMARY:
BILLING CODE 4140–01–P
VerDate Sep<11>2014
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institutes
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 959, Bethesda,
MD 20892, (301) 451–3397, sukharem@
mail.nih.gov.
Jkt 244001
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
1041
for the Teleconference/Webcast
participation is limited so early
registration is recommended.
• In Person: The address for this
meeting is 5600 Fishers Lane, 5th
(Main) Floor Pavilion rooms, Rockville,
Maryland 20852. The building is a
federal facility; prior registration, a
security screening and a federallyapproved identification (e.g., driver’s
license) are required to attend in-person.
Capacity for in-person attendance is
limited so early registration is
recommended.
Registration: Registration is required
for participation in the listening session
in person or via Teleconference/
Webcast. Registration is now open.
Registration for the in-person session
will close on 01/22/2018 at 12:00 p.m.
Eastern Time (ET). Registration for the
Teleconference/Webcast will close on
01/31/2018 at 8:30 a.m. ET. Persons
registering should indicate if they wish
to make a public comment. SAMHSA
recommends that when commenters
suggest changes or revisions to current
regulations that they indicate
specifically, when feasible, how such
regulation text should be revised. Only
one representative of an organization
may be allowed to present oral
comments. Presentations will be limited
to three minutes per speaker. SAMHSA
will try to accommodate all speakers
who wish to present based on the time
allotted for this meeting. Persons
making oral presentations are
encouraged to also submit written
comments as discussed below.
To register, go to: https://42-cfr-part2listening-session.eventbrite.com.
Special Assistance: Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify Rachel
Karton (contact information provided
below) at least 10 days prior to the
meeting.
Public Comments: In addition to
attending the session in person or
joining via Teleconference/Webcast, the
Agency offers several ways to provide
comments. SAMHSA recommends that
when commenters suggest changes or
revisions to current regulations that they
indicate specifically, when feasible,
how such regulation text should be
revised. You may provide comments
through the following means:
• Electronically: PrivacyRegulations@
SAMHSA.hhs.gov (preferred).
• Regular, Express or Overnight Mail,
or Hand Delivery or Courier: Written
comments must be sent to the following
address ONLY: Substance Abuse and
Mental Health Services Administration
(SAMHSA), Department of Health and
E:\FR\FM\09JAN1.SGM
09JAN1
]]>Agencies
[Federal Register Volume 83, Number 6 (Tuesday, January 9, 2018)]
[Notices]
[Pages 1040-1041]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00155]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Dental and Craniofacial Research Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Dental and Craniofacial
Research Council.
Date: January 31, 2018.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: Report to the Director, NIDCR.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Closed: 1:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Alicia J. Dombroski, Ph.D., Director, Division
of Extramural Activities,
[[Page 1041]]
National Institute of Dental and Craniofacial Research, National
Institutes of Health, Bethesda, MD 20892, 301-594-4805,
[email protected].
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.nidcr.nih.gov/about, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: January 2, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00155 Filed 1-8-18; 8:45 am]
BILLING CODE 4140-01-P
